About HOPE
News & Events
Product List
Contact Us
——
Company News
Recent Events
2026
Awarded the title of National High-tech Enterprise for nineteen consecutive years Named among the Top 50 Pharmaceutical R&D Companies of 2025–2026 Over 74 invention patents filed in total Over 150 technology transfers completed in total Multiple technological achievements commercialized; more than 40 series of products launched into industrial mass production
12
2026-08
2025
Named among the Top 50 Pharmaceutical R&D Companies of 2024-2025 Four pharmaceutical formulation products approved for marketing Over 70 invention patents filed in total Over 140 technology transfers completed in total
27
2024-02
2024
Awarded the title of 'National High-tech Enterprise' for 17 consecutive years Awarded the title of 'Top 20 Chinese Pharmaceutical R&D Companies' for 8 consecutive years Submitted registration applications for 10 formulation products in China, obtaining over 80 various registration approvals Obtained registration numbers for 10 active pharmaceutical ingredients from FDA, CDE, Taiwan Ministry of Health and Welfare, and other institutions Submitted 12 new patent applications, with a total of over 60 invention patents Achieved a cumulative factory technology transfer of over 130 items to client companies
2023
Awarded the title of 'National High-tech Enterprise' for 16 consecutive years Awarded the title of 'Top 20 Pharmaceutical R&D Companies in China' for 7 consecutive years Has obtained more than 70 clinical, production licenses, and new drug certificates approved by the National Medical Products Administration of China Has submitted more than 10 international registration applications to the FDA, EU, etc. Cumulatively achieved over a hundred technology transfers to client companies Completed multiple technology achievements transformation and industrialized production of over 30 series products
10
2022-01
2022
More than 20 new invention patent applications Two raw material drug varieties registered with CDE transferred to A Five formulation varieties obtained production licenses Shanghai branch established to strengthen business expansion and layout
07
2021
<strong>Obtain the first CEP certificate</strong>Obtain CNAS certification certificate First submission of MAH certification and obtain B certificate Two raw material drug varieties CDE transfer to A
